This is particularly evident in T1DM, where IL-10 inhibits autoreactive T cells targeting pancreatic β-cell (16), and in T2DM, where it mitigates inflammation in adipose tissue, alleviating insulin resistance (10). Here, IL10 is linked to type 2 diabetes mellitus.